Covered recipient · General Payments record
SHARON A STOKES
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2018–2024
$3,066.36
- Reported across 72 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $530.77 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Dermavant Sciences, Inc. | $178.43 | 2 |
| UCB, Inc. | $124.22 | 2 |
| ABBVIE INC. | $43.09 | 2 |
| LEO Pharma Inc. | $40.85 | 2 |
| Galderma Laboratories, L.P. | $35.18 | 2 |
| E.R. Squibb & Sons, L.L.C. | $23.58 | 1 |
| Janssen Biotech, Inc. | $22.50 | 1 |
| PFIZER INC. | $22.24 | 1 |
| Kerecis Limited | $20.99 | 1 |
| Incyte Corporation | $19.69 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $27.62 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106168161 | CMS |
| ABBVIE INC. | $15.47 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106168163 | CMS |
| Dermavant Sciences, Inc. | $149.60 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127939880 | CMS |
| Dermavant Sciences, Inc. | $28.83 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127939882 | CMS |
| E.R. Squibb & Sons, L.L.C. | $23.58 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101347306 | CMS |
| Galderma Laboratories, L.P. | $16.69 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145330593 | CMS |
| Galderma Laboratories, L.P. | $18.49 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145330595 | CMS |
| Incyte Corporation | $19.69 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141288670 | CMS |
| Janssen Biotech, Inc. | $22.50 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078432120 | CMS |
| Kerecis Limited | $20.99 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120099000 | CMS |
| LEO Pharma Inc. | $20.24 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152652919 | CMS |
| LEO Pharma Inc. | $20.61 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152652921 | CMS |
| PFIZER INC. | $22.24 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131306317 | CMS |
| UCB, Inc. | $47.22 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143452056 | CMS |
| UCB, Inc. | $77.00 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143452061 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.